NCT07285174Not yet recruiting
Shanghai Lymphoma Clinical Cohort
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
The aim of this study is to prospectively collect clinical information on patients with lymphoma, and to explore the best therapeutic strategies in the real-world population.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 3 Dec 2025
- Start date
- 18 Dec 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Ruijin Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT07285174
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 18 Dec 2025 to the primary completion date, 31 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who only receive supportive treatment.
- Patients who cannot obtain effective evaluation data of efficacy.
Who the study is looking for
- Age ≥ 16 years (including 16 years old).
- Patients newly diagnosed with non-Hodgkin lymphoma
- Patients who have received systematic clinical treatment.
- Patients with measurable lesions, at least containing one effective evaluation of efficacy.
Age in the registry: 16 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.